Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fosaveg 750mg tablets
1001050A0BVAAAB
|
Fosaveg | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Froben 100mg suppositories
1001010I0BBACAA
|
Froben | Flurbiprofen | Musculoskeletal and Joint Diseases | No data available |
|
Froben 100mg tablets
1001010I0BBABAC
|
Froben | Flurbiprofen | Musculoskeletal and Joint Diseases | No data available |
|
Froben 50mg tablets
1001010I0BBAAAB
|
Froben | Flurbiprofen | Musculoskeletal and Joint Diseases | No data available |
|
Froben SR 200mg capsules
1001010I0BBADAD
|
Froben | Flurbiprofen | Musculoskeletal and Joint Diseases | No data available |
|
FSC Glucosamine hydrochloride 1000mg tablets
1001050A0BZAAAI
|
FSC (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Galpharm Children's Ibuprofen 100mg/5ml oral suspension
1001010J0DFACBH
|
Galpharm (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galpharm Ibuprofen For Children 100mg/5ml susp 5ml sachets
1001010J0DFAABM
|
Galpharm (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galpharm Maximum Strength Ibuprofen 400mg liquid capsules
1001010J0DFABAU
|
Galpharm (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galpharm Migraine Relief 200mg capsules
1001010J0DFADAA
|
Galpharm (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galpharm Period Pain Relief 250mg gastro-resistant tablets
1001010P0BTAAAH
|
Galpharm (Naproxen) | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Galpharm Rapid Ibuprofen lysine 342mg tablets
1001010ADBHAAAB
|
Galpharm (Ibuprofen lysine) | Ibuprofen lysine | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen 100mg/5ml oral suspension
1001010J0CCADBH
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen 200mg tablets
1001010J0CCAAAD
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen Cold and Flu 200mg tablets
1001010J0CCABAD
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen Long Lasting 200mg capsules
1001010J0CCACBA
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen Long Lasting 300mg capsules
1001010J0CCAFAB
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen Migraine Relief 200mg capsules
1001010J0CCAEAA
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Generic Balmosa cream
1003020N0AAAKAK
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Generic Cremalgin Balm ointment
1003020T0AAADAD
|
Generic cream | Nicotinates | Musculoskeletal and Joint Diseases | No data available |
|
Generic Deep Heat rub
1003020N0AAATAT
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Generic Dubam spray
1003020N0AAAMAM
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Generic Goddards Muscle lotion
1003020V0AAAAAA
|
Generic embrocation | Turpentine oil | Musculoskeletal and Joint Diseases | No data available |
|
Generic Otezla tablets treatment initiation pack
1001030AAAAABAB
|
Apremilast | Apremilast | Musculoskeletal and Joint Diseases | No data available |
|
Generic Pain Relief balm cream
1003020T0AAAGAG
|
Generic cream | Nicotinates | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.